Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
Keywords: long-term safety; phase II studies; phase III studies; pooled analysis; psoriasis; secukinumab; AE; adverse event; ANC; absolute neutrophil count; BCC; basal cell carcinoma; CI; confidence interval; IBD; inflammatory bowel disease; IL; interleukin; IR; in